Acceptability Lactoserum (Dermacyd Delicata - New Fragrance)

Sanofi

Status and phase: Completed; Phase 4

Conditions: Hygiene

Treatments: Drug: Lactoserum

Study type: Interventional

Funder types: Industry

Identifiers

NCT00497783

LACTO_L_02949

Details and patient eligibility

About

The purpose of this study is to demonstrate the safety of the gynecological formulation in normal and usual usage condition of Dermacyd Femina Delicata.

Enrollment: 30 estimated patients

Sex: Female

Ages: 18 to 60 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Integral skin in the tested region

Exclusion criteria

• Pregnancy or breastfeeding women
• Use of Anti-inflammatory or immune-suppression drugs
• Topical medication use at the tested region
• Active cutaneous gynaecological disease which may interfere in study results
• Personal history of allergic disease at the area to be treated
• Allergic or atopic history

The above information is not intended to contain considerations relevant to a patient's potential participation in a clinical trial.

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)